IP Library Granted Patent US 12,460,175
Granted Patent B2
US 12,460,175 · App. 18/476,483 · Granted Nov 4, 2025

Methods and compositions for preserving bacteria

Inventors: Daniel E. Couto (Concord, MA); Shilpa Reddy (Watertown, MA); Jil Ulrich (Medford, MA); Scott Michonski (Belmont, MA)
Assignee: Vedanta Biosciences, Inc.
C12N1/04C12N1/20C12Q1/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,460,175
App. No.
18/476,483
Granted
Nov 4, 2025
Kind
B2
Abstract

The disclosure provides methods and compositions for the preservation of bacteria.

Claims (30)

1 . A composition comprising one or more bacterial strains belonging to the class Clostridia, a disaccharide other than lactose, an organic nitrogen source, an antioxidant, sodium metabisulfite, and a buffer at a pH of 6.7 to 7.3.

2 . The composition of claim 1 , wherein the disaccharide is sucrose.

3 . The composition of claim 2 , wherein the sucrose is at a concentration of 7.0% to 8.0%.

4 . The composition of claim 1 , wherein the disaccharide is trehalose.

5 . The composition of claim 4 , wherein the trehalose is at a concentration of 7.0% to 8.0%.

6 . The composition of claim 1 , wherein the sodium metabisulfite is at a concentration of 0.05%.

7 . The composition of claim 1 , wherein the buffer is at a pH of 7.0.

8 . The composition of claim 1 , wherein the composition comprises:

i) a bacterial strain comprising a 16S rDNA sequence having at least 97% sequence identity to a nucleic acid sequence of SEQ ID NO: 1;

(ii) a bacterial strain comprising a 16S rDNA sequence having at least 97% sequence identity to a nucleic acid sequence of SEQ ID NO: 2;

(iii) a bacterial strain comprising a 16S rDNA sequence having at least 97% sequence identity to a nucleic acid sequence of SEQ ID NO: 3;

(iv) a bacterial strain comprising a 16S rDNA sequence having at least 97% sequence identity to a nucleic acid sequence of SEQ ID NO: 4;

(v) a bacterial strain comprising a 16S rDNA sequence having at least 97% sequence identity to a nucleic acid sequence of SEQ ID NO: 5;

(vi) a bacterial strain comprising a 16S rDNA sequence having at least 97% sequence identity to a nucleic acid sequence of SEQ ID NO: 6;

(vii) a bacterial strain comprising a 16S rDNA sequence having at least 97% sequence identity to a nucleic acid sequence of SEQ ID NO: 7; and/or

(viii) a bacterial strain comprising a 16S rDNA sequence having at least 97% sequence identity to a nucleic acid sequence of SEQ ID NO: 8.

9 . The composition of claim 1 , wherein the organic nitrogen source is yeast extract, Luria-Bertani broth, or plant peptone.

10 . The composition of claim 1 , wherein the organic nitrogen source is yeast extract.

11 . The composition of claim 10 , wherein the yeast extract is at a concentration of 0.5% to 2.0%.

12 . The composition of claim 1 , wherein the antioxidant is inulin, riboflavin, or cysteine.

13 . The composition of claim 1 , wherein the antioxidant is cysteine.

14 . The composition of claim 13 , wherein the cysteine is at a concentration of 0.01% to 0.5%.

15 . The composition of claim 1 , wherein the buffer is a histidine buffer or a Tris buffer.

16 . The composition of claim 1 , wherein the composition comprises bacteria belonging to Clostridium clusters IV, XIVa, XVI, XVII, and/or XVIII.

17 . The composition of claim 1 , wherein the composition comprises one or more bacterial strains belonging to species selected from the group consisting of Clostridium bolteae, Anaerotruncus colihominis, Sellimonas intestinalis, Clostridium symbiosum, Blautia producta, Dorea longicatena, Clostridium innocuum , and Flavonifractor plautii.

18 . The composition of claim 1 , wherein the organic nitrogen source comprises a peptone.

19 . The composition of claim 18 , wherein the peptone is not derived from animal blood.

20 . A method for preserving bacteria of the class Clostridia, the method comprising

lyophilizing the composition of claim 1 .

21 . The method of claim 20 , wherein the bacterial strains belonging to the class Clostridia belong to Clostridium clusters IV, XIVa, XVI, XVII, and/or XVIII.

Assignments (2)
SECURITY INTEREST Recorded Jul 7, 2025
From: VEDANTA BIOSCIENCES, INC.
To: ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE
Reel/Frame 071622/0158 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2024
From: COUTO, DANIEL E.; REDDY, SHILPA; ULRICH, JIL; MICHONSKI, SCOTT
To: VEDANTA BIOSCIENCES, INC.
Reel/Frame 066423/0189 →
Continuity (4)
Continuation 17822860 · Aug 29, 2022
Continuation 16341583
Provisional Application 62414489 · Oct 28, 2016
Related Publication 20240141283A1 · May 2, 2024
References Cited (23)
US 5106743A · Franzblau et al. · 1992 [cited by applicant]
US 5891709A · Stern et al. · 1999 [cited by applicant]
US 11447738B2 · Couto et al. · 2022 [cited by applicant]
US 11814615B2 · Couto et al. · 2023 [cited by applicant]
US 20100297231A1 · Vehring et al. · 2010 [cited by applicant]
US 20110217368A1 · Prakash et al. · 2011 [cited by applicant]
US 20140206067A1 · Georgieva et al. · 2014 [cited by applicant]
US 20140341921A1 · Honda et al. · 2014 [cited by applicant]
US 20150258188A1 · Pizza et al. · 2015 [cited by applicant]
US 20150267245A1 · Hogan · 2015 [cited by applicant]
US 20180223244A1 · Ananta et al. · 2018 [cited by applicant]
CN 102260635A · 2011 [cited by applicant]
WO WO2012098358A1 · 2012 [cited by applicant]
WO WO2013068568A1 · 2013 [cited by applicant]
WO WO2015103450A1 · 2015 [cited by examiner]
WO WO2017001590A1 · 2017 [cited by applicant]
[No Author Listed], ATCC Medium: 1016 Chopped Meat Carbohydrate Medium. Nov. 23, 2014. Retrieved from web.archive.org/web/20141123091848if. Accessed on May 18, 2020. 1 page. [cited by applicant]
[No Author Listed], Sigma. Sigma Aldrich BioUltra Biological Buffers. Retrieved from www.sigmaaldrich.com/life-science/metabolomics/bioultra-reagents/biological-buffers.html. Accessed Dec. 29, 2020. [cited by applicant]
Staab et al., Viability of lyophilized anaerobes in two media. Cryobiology. Apr. 1987;24(2):174-8. doi: 10.1016/0011-2240(87)90020-4. [cited by applicant]
Haywood et al., Pharmaceutical excipients—where do we begin? Aust Prescr. Aug. 1, 2011;34:112-4. doi: 10.18773/austprescr.2011.060. [cited by applicant]
Peiren et al., Improving survival and storage stability of bacteria recalcitrant to freeze-drying: a coordinated study by European culture collections. Appl Microbiol Biotechnol. Apr. 2015;99(8):3559-71. doi: 10.1007/s0… [cited by applicant]
Bertani, The mode of phage liberation by lysogenic [cited by applicant]
Gibco, Technical Guid to Peptones, Supplements, and Feeds. ThermoFischer Scientific. 2020. 96 pages. [cited by applicant]